Welcome address

• Ivan Aranicki

  Vice President,
  Europe & Japan
  Oracle

The Future is now: Oracle & Cerner's Vision for Clinical Trials

The future of clinical trials is poised for major advancements with the combination of Oracle and Cerner's capabilities. Learn about our shared vision to enhance data quality, increase efficiency, and drive innovation in clinical trials.

• Ryan Kennedy

  Global Vice President, Product Strategy Experience and Enablement
  Oracle

How Modernised EHRs are Driving the Next Generation of Clinical Research

Learn how modernised electronic health records (EHRs) can enhance clinical trials by providing a comprehensive view of patient data, enabling personalised care and informed decision-making. Streamlined data collection and analysis can accelerate the development of new treatments and therapies.

• Distie Profit

  Vice President & Country General Manager, United Kingdom
  Oracle Cerner

• Dr Ameet Bakhai

  International Consultant Cardiologist,
  Royal Free London NHS

Clinical Research in a Post-Pandemic World: Insights from Sir John Bell

Sir John Bell, a world-renowned immunologist and geneticist, and key contributor to the AstraZeneca COVID-19 vaccine, delves into the post-pandemic world of clinical research. Get an in-depth look at how the pandemic has accelerated clinical trials and learn about innovative approaches to clincial research.

• Professor Sir John Bell

  Regius Professor of Medicine
  Oxford University

100 Million Patients and Beyond: How Real-World Studies are Impacting Clinical Trials

Real-world evidence generated from electronic health record (EHR) data is transforming the landscape of clinical trials. With access to a massive database of 100 million EHRs, researchers can now uncover insights and trends that were previously impossible to detect. This presentation will explore the potential of EHR-based real-world evidence and its impact on clinical research.

• Patricia Medina

  GM Medical Intelligence, RWE Data & Analytics
  Oracle Enviza

Revolutionising Drug Safety: From Data to Decisions

Explore the future of pharmacovigilance including challenges and opportunities faced by safety professionals, and advances in technology that can help address these needs. Gain insights to stay ahead in this ever-evolving field & ensure patient safety.

• Dr Sameer Thapar

  Global Multivigilance Head, Customer Centre of Excellence
  Oracle

• Michael Braun-Boghos

  Senior Director Safety Strategy
  Oracle

Unlocking the Potential of DCT: Best Practices and Lessons Learned

Decentralized clinical trials (DCTs) have the potential to radically change the way clinical trials are conducted, leading to improved accessibility, diversity, and retention. They naturally involve more complex sources of data — physical sites, electronic health records, wearables, and mobile apps. Learn best practices and lessons learned on how to maximise value from these approaches.

• Ivan Jarry

  Chief Executive
  ObvioHealth

Accenture: Driving R&D Performance and Efficiency

How can we mitigate remaining challenges in Clinical Research? We will have new opportunities with next generation technologies and the cloud utilizing a patient centric approach and (re)defining global data standards & interoperability.

• Mathias Eichler-Mertens

  Managing Director, Life Sciences R&D
  Accenture

Journey to Intelligent Automation in Pharmacovigilance

Based on the experience of over 100 companies and speakers who have shared their cases in an independent ISoP Boston Seminar on Intelligent Automation in Pharmacovigilance over the last 6 years, valuable lessons could be developed for strategic decisions of those in charge of investment in information technology worldwide.

• Robert Scheiner

  CEO
  iVigee

Accelerating Cycle Times: Insights from CROs on Embracing Innovation

CROs are paving the way for a better future by adopting innovative clinical applications to boost efficiency, foster collaboration and aid in trial performance in an ever-competitive environment. Join our panel of CRO experts as they discuss technologies and processes that are having an impact.

• Baljit Klear

  CRO Alliance Director
  Oracle

• Siegfried Vanderbeke

  Senior Director Operations
  Clinitude

• Paul Hastwell

  Principal, Transformation Consulting
  IQVIA

• Nicholas Lakin

  Senior Managing Director, Consulting
  Syneos Health

Innovating with Real World Data: Overview of Global Regulatory Trends

The cadence of new regulations is increasing adding to the burden of safety professionals. Gain insightful knowledge on how global regulatory trends are evolving, how compliance can be achieved, and how regulations are creating new opportunities in clinical research to shape the future of the industry.

• Una Kessi

  Product Management Director, Safety and Pharmacovigilance
  Oracle

DNA Day! Optimizing use of Genomics Data in Clinical Research

Explore the optimisation of genomics data in clinical research through the application of FAIR (Findable, Accessible, Interoperable and Reusable) principles, in celebration of DNA Day. Learn about the challenges and opportunities of using genomics data in clinical research settings and strategies for maximising its use for better patient outcomes.

• Ana Teixeira

  Principle Product Manager- Multiomics
  Oracle

Transformational Initiatives: Driving Success with Oracle

Discover how Oracle collaborates effectively to assist organisations in realising their transformation goals throughout the clinical trial process. The journey includes co-innovation, business evaluations, established methods, empowerment, guidance, industry peer engagement, and professional services, providing increased value from Oracle and our partner network.

• Srinivas Karri

  Global Head, Customer Centre of Excellence
  Oracle

Drinks Reception in the Foyer